UTH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - United Therapeutics Corp

Watchlist Manager

Watchlist

Price: 457.4 EUR -1.36% Market Closed

Market Cap: €20.4B

U	United Therapeutics Corp F:UTH	US
G	Genco Shipping & Trading Ltd F:GNU1	US
A	Argan Inc F:1AW	US
	Chemomab Therapeutics Ltd F:2QV0	IL
	Oncozenge AB F:8LY	SE
	Gimv NV F:GI3	BE
	Alexander's Inc F:AXE	US
	Contemporary Amperex Technology Co Ltd F:C7A0	CN
	Foresight Group Holdings Ltd F:9LR	UK
	Can Fin Homes Ltd BSE:511196	IN
	Midea Group Co Ltd F:1520	CN

Profitability Summary

United Therapeutics Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

87%

Strong 3Y Average Gross Margin

89%

Declining Gross Margin

90% > 87%

Exceptional Operating Margin

45%

Strong 3Y Average Operating Margin

49%

Declining Operating Margin

52% > 45%

Exceptional Net Margin

41%

Strong 3Y Average Net Margin

41%

Declining Net Margin

41% > 41%

Exceptional Free Cash Flow Margin

32%

Strong 3Y Average Free Cash Flow Margin

34%

Declining Free Cash Flow Margin

32% > 32%

Positive ROE

20%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

28%

ROIC is Increasing

25% > 28%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.